{"nct_id":"NCT05356741","title":"To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-04-13","start_date_type":"ACTUAL","primary_completion_date":"2027-08-16","primary_completion_date_type":"ESTIMATED","completion_date":"2027-08-16","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["VIR"]}